Bristol-Myers Squibb, Ventiv ink multi-year service deal

Share this article:
Bristol-Myers Squibb and Ventiv Pharma Services have signed a multi-year service agreement under which Ventiv will provide a sales force of more than 375 representatives focusing on Cefzil and Tequin.
Under the terms of the agreement, Ventiv Pharma also will provide BMS with the entire field and internal management staff, full operational support to include sales force automation, help desk support and analysis and reporting services, according to a Ventiv statement. Ventiv Pharma is a division of Ventiv Health Inc.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.